Patient Access Navigator

Who We Are: Cogent Biosciences is a leading biotechnology company publicly traded and dedicated to developing innovative precision therapies to address significant medical needs. Our flagship program, bezuclastinib, effectively targets exon 17 mutations in the KIT receptor tyrosine kinase, including the KIT D816V variant, which is linked to Systemic Mastocytosis and gastrointestinal stromal tumors (GIST). With encouraging data from multiple clinical trials, including APEX, SUMMIT, and PEAK, bezuclastinib demonstrates a strong safety profile and potential for positive patient outcomes. The Role: We are looking for compassionate and driven Patient Access Navigators to pioneer our Patient Services team. As a Patient Access Navigator, you will be instrumental in providing a comprehensive, patient-centered access experience throughout the prescription fulfillment process. You will manage the entire patient journey in your designated geographic area and collaborate closely with patients, caregivers, healthcare providers (HCPs), specialty pharmacies, and internal and external partners to ensure timely access to therapies and continuity of care. Although this role is primarily home-based with occasional office visits at our Waltham Headquarters (two days a week), you will be expected to support complex access, reimbursement, or care coordination needs as required. We seek team members who are empathetic, detail-oriented, and committed to operational excellence as we prepare for the launch of bezuclastinib.

Zenas BioPharma is a forward-thinking clinical-stage global biopharmaceutical company dedicated to leading the development and commercialization of groundbreaking therapies for patients suffering from autoimmune diseases. Our strategy leverages the expertise of our seasoned leadership team combined with a meticulous approach to the acquisition and development of product candidates that we believe will provide significant clinical advantages for patients with autoimmune disorders. Zenas is actively progressing two late-stage potential franchise molecules: obexelimab and orelabrutinib. Obexelimab—our flagship product candidate—is a bifunctional monoclonal antibody engineered to bind to both CD19 and FcγRIIb, which are extensively expressed across B cell lineages. This innovative approach aims to inhibit the activity of cells involved in various autoimmune diseases without depleting them. We are confident that obexelimab’s unique mechanism of action and its self-administered, subcutaneous injection regimen will effectively target the harmful role of B cells in chronic autoimmune conditions. Orelabrutinib is a potentially best-in-class, highly selective oral small molecule Bruton’s Tyrosine Kinase (BTK) inhibitor, designed to address focal inflammation and disease progression in Multiple Sclerosis (MS). Our earlier-stage programs include a preclinical oral IL-17AA/AF inhibitor and a preclinical oral brain-penetrant TYK2 inhibitor.We are in search of exceptional talent who are passionate about making a difference in patients' lives and possess a proven track record in the global acquisition, development, and commercialization of pharmaceutical products. Joining our team offers the chance to thrive in a dynamic, fast-paced environment while contributing to our mission of becoming a global leader in immunology and autoimmune disease treatment. Our core values are Transparency, Relationships, Urgency, Excellence, and true Innovation!Position Summary:The Senior Director of Access Strategy & Patient Services will be pivotal in strategizing and leading our patient access initiatives, ensuring smooth operations for patient services to facilitate timely and appropriate access to Zenas BioPharma therapies. Reporting directly to the Vice President of U.S. Market Access, this role will oversee the development of the patient journey strategy, the HUB services model, affordability programs, and the onboarding processes for providers to help both patients and providers navigate access to therapy effectively.This role is crucial in establishing the patient access infrastructure ahead of significant product launches, operationalizing the patient support HUB, and designing prior authorization support systems to enhance patient access.

As the Director of Market Access Pricing & Analytics, you will play a pivotal role within our US Market Access team. This leadership position is essential for delivering impactful insights that shape our pricing, contracting, and reimbursement strategies. You will leverage advanced analytics, strategic acumen, and cross-functional collaboration to support key business decisions aimed at enhancing patient access. In this role, you will identify opportunities, evaluate risks, align stakeholders, and translate data into actionable strategies to achieve our market access objectives.

Join Sobi as an Associate Director of Access Strategy, where you will play a critical role in shaping access strategy initiatives that enhance patient access to innovative therapies. Collaborate with cross-functional teams to develop comprehensive strategies that address barriers to access and ensure that patients receive the treatments they need. Your expertise will influence strategic decision-making and drive successful outcomes in the evolving healthcare landscape.

Deciphera Pharmaceuticals is seeking a dynamic and strategic leader to join our team as the Vice President of US Market Access. In this pivotal role, you will be responsible for developing and executing comprehensive market access strategies that ensure our innovative therapies reach the patients who need them. You will collaborate closely with cross-functional teams, including commercial, medical affairs, and regulatory, to optimize the market positioning and reimbursement landscape for our product portfolio.The ideal candidate will possess deep expertise in market access, payer strategy, and the pharmaceutical industry landscape. You will leverage your leadership skills to drive initiatives that enhance our market presence and ensure the successful launch of our products in the US market.

The Medical Excellence Manager will play a pivotal role in overseeing Investigator Sponsored Studies (ISS), Managed Access Programs (MAP), and Post Trial Access (PTA) Programs. The successful candidate will be tasked with:Managing the ISS review and approval process, ensuring thorough proposal validation, coordination of reviews, and effective communication of decisions to stakeholders.Oversight of the MAP/PTA review and approval process, which includes coordinating case reviews, documenting decisions, and engaging with relevant parties.Acting as the global point of contact for ISS and MAP management concerning specified products, collaborating with cross-functional internal and external stakeholders.Maintaining detailed databases for ISS and MAP/PTA, meticulously tracking proposals, studies, and decisions along with necessary documentation.Facilitating contract development and negotiations between sponsors/requestors and Sobi, working closely with legal and other departments as necessary.Supporting supply chain setup in partnership with Affiliate teams and Sobi Supply Chain for both ISS and MAP/PTA programs.Providing regular status updates on ISS and MAP/PTA programs to relevant teams and leadership.Monitoring milestone payments and reporting the ISS budget to budget owners.Coordinating with vendors for the setup and management of MAP and PTA programs as needed.

Who We Are:Cogent Biosciences is a publicly traded biotechnology firm dedicated to pioneering innovative precision therapies aimed at addressing diverse patient needs in the medical field. Our flagship program, bezuclastinib, is engineered to selectively and effectively inhibit exon 17 mutations present in the KIT receptor tyrosine kinase, notably including KIT D816V. This mutation is a primary driver of Systemic Mastocytosis, a rare and serious disease, while exon 17 mutations are also implicated in gastrointestinal stromal tumors (GIST), a cancer type reliant on aberrant KIT signaling. Bezuclastinib has demonstrated promising outcomes in early trials: APEX in AdvSM, SUMMIT in NonAdvSM, and PEAK in GIST, showcasing a favorable safety profile across more than 600 patients in both standalone and combination therapies.Position Overview:The National Account Director (NAD) is tasked with securing profitable coverage access with national payer organizations, including GPOs, PBMs, and major regional account clients.This role is pivotal in executing our Market Access objectives and strategies directed at the payer audience.The NAD will collaborate with various internal teams such as Market Access, Marketing, Commercial Operations, Sales, and Medical to align strategies with our key clients, ensuring optimal experiences for both patients and providers.Key Responsibilities:Implement tailored customer strategies that align with our overall product and business objectives.Communicate the value of our offerings by managing relationships with all customer stakeholders.Design and execute corporate strategies tailored to the market access payer landscape, maximizing Cogent's access and profitability.Lead discussions with key strategic accounts, including clinical and contracting negotiations as necessary.Stay informed on developments among government and private insurers to inform Market Access strategies, enabling proactive responses to market changes.Establish, nurture, and expand relationships with senior executives at key accounts.

Join our dedicated team as a Healthcare Customer Service Representative, where you will play a vital role in supporting patients and healthcare providers. Your primary responsibilities will include addressing inquiries, resolving issues, and ensuring a positive experience for all stakeholders. We are looking for individuals who are passionate about healthcare and possess excellent communication skills.